BHRT Stock News Bioheart Inc. (BHRT) 0.0280 07/26/2014 15:21

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bioheart Inc. (BHRT) 0.0280 $BHRT

Bioheart Announces World's First Combination Stem Cell Treatment
Marketwire - Thu Jul 24, 7:23AM CDT
Bioheart, Inc. (OTCQB: BHRT) announced today that it has completed the world's first combination stem cell treatment with Magnum Cell Therapies (Magnum) in Honduras. A patient with congestive heart failure has been treated with a combination of AdipoCell(TM) or adipose derived stem cells and MyoCell(R) or muscle derived stem cells. AdipoCell may help to promote angiogenesis or new blood vessel formation in ischemic tissue while MyoCell may help to promote myogenesis or new muscle formation. The cells were delivered directly into the damaged areas of the heart using the MyoCath(R) Catheter.

Bioheart Announces Grand Opening of Magnum Cell Therapies
Marketwire - Wed Jul 16, 7:02AM CDT
Bioheart, Inc. (OTCQB: BHRT) announced today that it will participate in the grand opening event of Magnum Cell Therapies (Magnum) in Honduras during the week of July 21st. Bioheart has previously announced the joint venture with Magnum and the goal to bring regenerative therapies to patients in South America.

Bioheart Announces Clinical Trials in India
Marketwire - Mon Jul 07, 7:01AM CDT
Bioheart, Inc. (OTCQB: BHRT) announced today that they have begun two clinical trials in India including the first ever combination stem cell trial in the world. The first cardiac patient has successfully been enrolled and treated in India using AdipoCell(TM) or adipose derived stem cells. The second trial will involve the combination of AdipoCell and MyoCell(R) or muscle derived stem cells for congestive heart failure patients. AdipoCell may help to promote angiogenesis or new blood vessel formation in ischemic tissue while MyoCell may help to promote myogenesis or new muscle formation.

Bioheart Announces Joint Venture in South Africa
Marketwire - Tue Jun 24, 7:01AM CDT
Bioheart, Inc. (OTCBB: BHRT), a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of degenerative diseases, announced today that it has entered into a joint venture with Dr. Walter Bell of South Africa.

Bioheart to Present at the PRP and Regenerative Medicine Symposium (TOBI 2014)
Marketwire - Thu Jun 05, 2:05AM CDT
Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies, announced that it will present at the 5th annual PRP & Regenerative Medicine Symposium on June 6-7 (TOBI 2014). The Orthobiologic Institute (TOBI) was established to share best practices in the cutting-edge field of Platelet Rich Plasma (PRP) and regenerative medicine therapies. The Orthobiologic Institute's live events are known for their global draw and opportunity to connect with physicians in this rapidly growing field with intensive hands-on programs. Kristin Comella, Bioheart's Chief Scientific Officer, will present data from cardiac and orthopedic studies.

A New Audio Interview With Kristin Comella, Chief Science Officer for Bioheart, Inc., is Now at SmallCapVoice.com
GlobeNewswire - Mon Jun 02, 8:34AM CDT
SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with Bioheart, Inc. (OTCQB:BHRT), a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies, is now available. The interview can be heard at http://smallcapvoice.com/blog/5-28-14-smallca...t-inc-bhrt

Bioheart to Present at the World Stem Cells & Regenerative Medicine Congress
Marketwire - Fri May 16, 7:01AM CDT
Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies, announced that it will present at the 9th annual World Stem Cells & Regenerative Medicine Congress on May 20th-21st, 2014 in London, England. The World Stem Cells & Regenerative Medicine Congress is a place where innovation and expertise are showcased, solutions are found and learning is done.

Bioheart Reports Significant Revenue Increases
Marketwire - Thu May 15, 7:03AM CDT
Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies, announced today its financial results for the first quarter of 2014.

Bioheart to Present at SELECTBIO Clinical Translation of Stem Cells
Marketwire - Wed Apr 02, 7:03AM CDT
Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies, announced that it will present at the SELECTBIO 2nd Annual Clinical Translation of Stem Cells on April 21st, 2014. The conference brings together basic scientists, clinician-scientists, as well as medical practitioners/surgeons focusing on studying, characterizing, and deploying various classes of stem cells for therapeutic utility.

Bioheart Announces Clinical Study for Degenerative Disc Disease
Marketwire - Wed Mar 26, 1:16PM CDT
Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies, announced that it will enroll patients in a new study for degenerative disc disease (DDD). The study will enroll up to 100 patients to determine the safety and efficacy of adipose derived stem cells or AdipoCell(TM) in patients with DDD.

Bioheart, Inc. Announces Mike Tomas, President/CEO, Has Been Chosen as an Honoree for Emerge Americas Techweek100 Miami 2014
Marketwire - Tue Mar 25, 7:03AM CDT
Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies, announced that Mike Tomas, President and CEO, has been named as one of the top 100 technology leaders on eMerge Americas Techweek100 Miami 2014. (http://techweek.com/miami/techweek100/).

Bioheart, Inc. to Present at American Association of Orthopedic Medicine on Cell Therapy
Marketwire - Fri Mar 21, 7:01AM CDT
Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies, announced that it will present at the 31st American Association of Orthopedic Medicine Annual Conference (AAOM) Conference and Scientific Seminar. Co-sponsored by the American Board of Quality Assurance and Utilization Review Physicians, Inc. (ABQAURP), the conference, titled "Sports, Spine and Beyond: Latest Advances in Regenerative Orthopedic Medicine," will focus on the newest breakthroughs in the field of orthopedic medicine.

Galena Biopharma Inc. Share Value Tumbles on News of SEC Investigation
ACCESSWIRE - Wed Mar 19, 10:25AM CDT
Galena Biopharma Inc. (NASDAQ:GALE) share volume soared Mar. 18, with more than 17,653,116 shares changing hands, nearly double its three-month average volume of 9,373,933 shares, while its share value continued to tumble, closing at $2.82, down 40 cents, or 12.42%, from its closing price of $3.22 the previous day. The high volume and stock value tumble are being triggered by the Worcester, Mass-based company's revelation that it is being investigated by the Securities and Exchange Commission. Here is the company's statement: "In February 2014, we learned that the SEC is investigating certain matters relating to our company and an outside investor-relations firm that we retained in 2013. We have been in contact with the SEC staff through our counsel and are cooperating with the investigation," the company stated in its 10-K filing dated Mar. 17. Class-Acton Lawsuits In addition to this bad news, the company is facing a slew of class action lawsuits from stockholders that allege Galena and certain of its executives issued a series of materially false and misleading statements during the Class Period, violating federal securities laws. However, it should be noted that none of these allegations have been proven. Moreover, Galena's results for its fourth quarter were less than comforting to shareholders. Its earnings per share loss of (46c) on revenue of $1.32M as compared to estimates of (9c) and $1.62M, respectively. The company pointed out that the Q4 net loss of $48.5M included $38.9M in non-cash charges. On the positive side, the company lifted its 2014 Abstral net revenue estimates to $11M-$15M as compared to prior guidance of $8M-$12M. Analysts' Consensus Nonetheless, of the 9 analyst firms that cover Galena, 7 rate it a "strong buy," 1 a "buy" and 1 a "sell." Find out what could be the best investor's move when it comes to GALE by getting the complete report here, or by cutting and pasting the following link in your Web browser: http://www.sixfigurestockpicks.com Bioheart Inc.'s Stock Volume Soars on News of Joint Venture with Magnum Cell Therapies Meanwhile, development-stage, biotechnology company Bioheart Inc.'s (OTCQB: BHRT) stock volume continued to soar Mar. 18, with 7,457,880 shares changing hands, nearly three times more than its three-month average volume of 2,607,553 shares.

Bioheart Announces Joint Venture With Magnum Cell Therapies
Marketwire - Mon Mar 17, 7:19AM CDT
Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of degenerative diseases, announced today that it has entered into a joint venture with Magnum Cell Therapies (http://www.magnumterapiacelular.com/).

Generex Biotechnology Corp. Granted Patents on New HPV and Influenza Vaccines
ACCESSWIRE - Wed Mar 12, 11:01AM CDT
Generex Biotechnology Corp. (OTCQB: GNBT) stock volume soared Mar. 11, with 9,325,106 shares changing hands, significantly higher than its three-month average volume of 7,012,285 shares.

Bioheart Boosts Team With Regulatory, Finance and Administrative Expertise
Marketwire - Fri Sep 20, 12:10PM CDT
Bioheart (OTCQB: BHRT), a leader in developing stem cell therapies to treat cardiovascular diseases, has expanded its team by adding three key strategic positions with regulatory, finance and administrative expertise.

Bioheart Inc adds Sheldon T Anderson to board
M2 - Thu Aug 29, 6:05AM CDT
Biotech company Bioheart Inc (OTCQB:BHRT) stated on Wednesday that Sheldon T Anderson has been named to its board of directors.

Sheldon T. Anderson Elected to the Board of Directors of Bioheart, Inc.
Marketwire - Wed Aug 28, 7:02AM CDT
Sheldon T. Anderson has been elected to the Board of Directors of Bioheart, Inc. (OTCQB: BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies for the treatment of chronic and acute heart damage as well as severe peripheral vascular disease. Mr. Anderson is Chairman of the Advisory Board of Northern Trust. He retired last year as Chairman and CEO of the Southeast Region of Northern Trust, where he was responsible for managing the company's investment management, trust and estate planning, private and business banking and financial consulting business in Florida and Georgia.

Bioheart's President / CEO Mike Tomas Appointed to Workforce Florida Board of Directors by Governor Rick Scott
Marketwire - Wed Aug 14, 7:21AM CDT
Bioheart, Inc. (OTCQB: BHRT) announced today that Mike Tomas, the company's President/CEO, has been appointed to serve on Workforce Florida's Board of Directors for a four year term by Florida Governor Rick Scott. Tomas is one of 15 Floridians appointed to the Board of Directors. Workforce Florida is charged with overseeing the state's workforce system and developing strategies that will improve the state's business environment while supporting its economy (www.EmployFlorida.com).

OTC Daily Alert Stock Watch - Bioheart (OTCBB:BHRT)
WorldStockWire - Tue Aug 13, 12:00PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASU's International Enrollment Lead Carries Real Weight

Updated Category News Views 108

Twenty thousand nine hundred twenty-six international students is not a campus footnote; it is a serious operating force moving through Arizona State University and the state around it. ASU has held the No. 1 spot among U.S. public universities hosting international students for six straight years, and the 2026 Open Doors report puts it No. 2 across public and private...

Continue Reading
Neurelis Founder Earns EY's 2026 Top Entrepreneur Honor

Updated Category News Views 95

Some business awards are wallpaper; this one carries real clinical weight. EY US named Craig Chambliss, CEO and co-founder of Neurelis, its Entrepreneur Of The Year 2026 National Overall Award winner. In a sector where plenty of companies talk grandly about changing lives and then vanish into the regulatory fog, the underlying story matters more than the trophy. Neurelis...

Continue Reading
Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 138

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 147

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading
Epiroc Takes Live Remote Drilling to CES 2027 Stage

Updated Category News Views 48

A drill rig chewing through Virginia rock from a Las Vegas convention booth is either a serious industrial-tech moment or an expensive magic trick. At CES 2027, Epiroc intends to make the distinction painfully clear. From January 6 through 9, the Stockholm-based mining-equipment company and Luck Stone will connect Booth 7031 in the LVCC West Hall to a working quarry in...

Continue Reading
Lara Kirchner's Surgical Leadership Earns Recognition

Updated Category News Views 64

Surgical care gets judged in the quiet moments nobody puts on a plaque: a sterile instrument ready when it must be, a handoff done cleanly, a team that does not let a rushed schedule turn into a bad outcome. That is why Lara L. Kirchner's recognition as a Pinnacle Professional of the Year deserves a more serious look than the usual congratulatory confetti. Kirchner is...

Continue Reading
CVS Puts Youth Soccer Stories on Its Store Shelves

Updated Category News Views 76

Two kids with real community ties just got a megaphone most grown-ups never receive. CVS Pharmacy has named Caroline, 9, of Holmes Beach, Florida, and Zoe, 12, of Los Angeles, as the first grand-prize winners of its Home Team Heroes youth soccer contest. Each player’s selected nonprofit soccer organization will receive a $25,000 grant, while their stories will appear on...

Continue Reading
West Virginia SEO Timelines Demand Patience, Not Hype

Updated Category News Views 99

A fresh website with no search footprint is not a race car; it is a pickup stuck in mud, and Sean O'Kelly's view of local SEO in West Virginia puts that inconvenient fact right on the table. Most businesses can expect measurable improvement after three to six months of consistent work, according to the HelloNation article. That is not a glamorous answer, but it is the...

Continue Reading
Triller Lawsuit Puts Merger Disclosures Under a Harsh Light

Updated Category News Views 90

A $0.32 closing price has a way of stripping the paint off a corporate story. The proposed securities class action involving Triller Group, Inc. puts a hard spotlight on a familiar, ugly market sequence: a splashy merger, glowing talk around acquired assets, delayed financial filings, Nasdaq trouble, and then a collapse severe enough to leave shareholders wondering what...

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 27

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading

Top 5 Most Recently Viewed Articles

Director Declaration - Northern 2 VCT PLC

Updated Category News Views 143

Director Declaration - Northern 2 VCT PLC Northern 2 VCT PLC (“the Company”) has announced that Ranjan Ramparia, who currently serves as a non-executive director and audit Chair of the Company, will take on a new role as a non-executive director at Keystone Positive Change Investment Trust plc. Disclosure Compliance In line with the UK Listing Rules, there are no...

Continue Reading
Exploring WisdomTree's Diverse Fund Offerings and Prices

Updated Category News Views 119

Understanding WisdomTree's Daily Fund Prices WisdomTree Issuer plc, renowned for its innovative investment strategies, provides a range of ETF products that cater to various investment needs. The company focuses on not just traditional asset classes but also on megatrends shaping the future. Investors looking to stay updated on their financial assets can explore the daily...

Continue Reading
Atlantic American Corporation Sees Positive Growth in Q1 Results

Updated Category News Views 198

Atlantic American Corporation Achieves Strong Q1 Performance Atlantic American Corporation (NASDAQ: AAME) recently announced its financial results for the first quarter of the year, showcasing a significant turnaround in performance. The company reported a net income of $0.8 million, translating to $0.03 per diluted share. This marks a remarkable recovery from a net loss...

Continue Reading
CTT's Growth in Q3 2024: A Promising Outlook for Q4

Updated Category News Views 80

CTT's Impressive Q3 Performance CTT (CTT.LS) reported a stellar third quarter, showcasing significant revenue growth and a bright outlook for the fourth quarter. As discussed by CEO Joao Bento, the company achieved a remarkable 17.3% increase in revenue, accompanied by a 28.6% rise in EBIT when excluding Financial Services. This transition period highlights CTT's...

Continue Reading
Global Leaders Unite for Climate Justice Summit in NYC

Updated Category News Views 186

Global Leaders Come Together for Climate Justice Summit in NYC The Climate Justice Summit: People Deliver marks a significant kickoff for Climate Week in New York City. This vibrant event will gather a broad spectrum of climate justice advocates from around the world, who will collaborate and share their insights. A coalition of key organizations, including the HBCU Green...

Continue Reading